Table 8.
TCM | Tools | Results | Ref |
---|---|---|---|
ShuFeng JieDu capsule | TCMSP; GeneCards; DAVID; R software |
Key targets: RELA, MAPK1, MAPK14, CASP3, CASP8 and IL6. KEGG signaling pathways: Kaposi sarcoma-associated herpesvirus infection, AGE-RAGE signaling pathway in diabetic complications, Human cytomegalovirus infection, IL-17 signaling pathway and Hepatitis B, etc. |
[53] |
Huashi Baidu formula | TCMSP; GeneCards; Cytoscape; STRING |
Key targets: MAPK3, MAPK8, TP53, CASP3, IL6, TNF, MAPK1, CCL2, PTGS2, etc. KEGG signaling pathways: TNF signaling pathway, PI3K-Akt signaling pathway, NOD-like receptor signaling pathway, MAPK signaling pathway, and HIF-1 signaling pathway. Molecular docking: Baicalein+ACE2; Quercetin+ACE2. |
[54] |
Toujie Quwen granule | TCMSP; Swiss Target Prediction; STRING; R software; Cytoscape |
Key active ingredients: umbelliprenin, quercetin, kaempferol, luteolin, praeruptorin E, stigmasterol, and oroxylin A. Key targets: EGFR, CASP3, STAT3, ESR1, FPR2, F2, BCL2L1, BDKRB2, MPO, and ACE. Signaling pathways: regulation of inflammatory response, viral process, neutrophil mediated immunity, PI3K-Akt signaling pathway, MAPK signaling pathway, Jak-STAT signaling pathway, Complement and coagulation cascades, and HIF-1 signaling pathway. |
[55] |
Ma Xing Shi Gan Decoction | TCMSP; PharmMapper; Swiss Target Prediction; STITCH; Cytoscape; STRING R software |
Key targets: HSP90, AKT1, JUN, MAPK1, TP53, ESR1, VEGFA, and TNF. KEGG signaling pathways: inflammation-related pathways, immunomodulation-related pathways, and viral infection-related pathways. Mechanisms: reducing inflammation, suppressing cytokine storm, protecting pulmonary alveolar-capillary barrier, alleviating pulmonary edema, regulating immune response, and decreasing fever. |
[56] |
Qing-Fei-Pai-Du decoction | UHPLC-Q-Orbitrap HRMS; DrugBank; PubChem; STITCH; ETCM; GTEx; STRING; Cytoscape |
Key active ingredients: baicalin, glycyrrhizic acid, hesperidin, and hyperoside. Key targets: AKT1, TNF-α, IL6, PTGS2, HMOX1, IL10, and TP53. Molecular docking: Baicalin+ HMOX1/ PRKACA/ COMT/ CSNK2B; Ephedrine+ COMT/ PLAT; Hesperidin+ HMOX1; Hyperoside+ HMOX1/ PRKACA/ COMT/ CSNK2B; Isochlorogenic acid A+ HMOX1; Pseudoephedrine+ GLA; Glycyrrhizic acid+ HMOX1. In intro experiments: inhibiting IL6, CCL2, TNF-α, NF-κB, PTGS1/2, CYP1A1, CYP3A4 activity, the up-regulation of IL10 expression, and repressing platelet aggregation. |
[57] |
Lian Hua Qing Wen | TCMSP; ETCM; STRING; Cytoscape |
KEGG signaling pathways: cancer, immune system-, and viral infection diseases. Mechanisms: modulating the inflammatory process, exerting antiviral effects, repairing lung injury, relieving the “cytokine storm” and improving ACE2-expression-disorder-caused symptoms. |
[58] |
Maxingyigan Decoction | TCMSP; STRING; Cytoscape |
Molecular docking: Quercetin/Formononetin/Luteolin+ IL6/ CASP3/ IL4/ SARS-CoV-2. Mechanisms: anti-inflammatory and immunity-based actions involving activation of T cells, lymphocytes, and leukocytes, as well as cytokine-cytokine-receptor interaction, and chemokine signaling pathways. |
[59] |
Cold-Damp Plague Formula | TCMSP; TCMID; Swiss ADME; STITCH; GeneCards; STRING; Cytoscape; |
Key targets: IL6, TNF, IL10, MAPK8, MAPK3, CXCL8, CASP3, PTGS2, TP53, and MAPK1. KEGG signaling pathways: TNF signaling pathway, MAPK signaling pathway, Fc epsilon RI signaling pathway, toxoplasmosis, leishmaniasis, and so on. Molecular docking: Quercetin/Luteolin+IL6; L-tyrosine/L-phenylalanine+ACE2. |
[60] |
Respiratory Detox Shot | TCMSP; TCMID; ETCM; Swiss Target Prediction; SEA; TargetNet; HINT; Cytoscape; CPDB; DAVID; STRING |
Molecular docking: One-hundred and eighteen candidate constituents showed a high binding affinity with SARS-coronavirus-2 3-chymotrypsin-like protease (3CLpro). Key active ingredients in vitro experiments: Luteolin, Licoisoflavone B, Fisetin, Quercetin, Glyasperin F, Isolicoflavonol, Semilicoisoflavone-B. |
[61] |
Rhizoma Polygonati | TCMSP; Swiss Target Prediction; GenCLiP3; NCBI; GeneCard; STRING; DAVID; Cytoscape |
Key active ingredients: diosgenin, 3′-Methoxydaidzein, 4′,5-Dihydroxyflavone, (2R)-7-hydroxy-2-(4-hydroxyphenyl)chroman-4-one, , DFV, Lopinavir, Remdesivir, (+)-Syringaresinol-O-beta-D-glucoside, beta-sitosterol, sitosterol, baicalein, methylprotodioscin_qt. Key targets: CASP3, TP53, MAPK14, PTGS2, CAT, FOS, PPARG, CASP8, BCL2L1, IL2, RELA. KEGG signaling pathways: tuberculosis, p53 signaling, AGE-RAGE in diabetic complications, IL-17 cytokine, apoptosis, and viral infection. Molecular docking: Diosgenin/ (+)-Syringaresinol-O-beta-D-glucoside+ ACE2/3CL/ Spike protein S1/ RNA-dependent RNA polymerase. |
[62] |